BioLife shares converted into cash and Repligen shares, and BioLife ceased to exist. The filing does not show whether the exchange left holders better or worse off.
Former BioLife holders receive cash and Repligen shares, but the filing does not compare that exchange with BioLife's value before the deal. BioLife also no longer exists, so this filing provides no continuing business results to judge. The exchange alone does not establish a gain or loss for its holders.
Repligen completed a deal that gives BioLife holders cash and Repligen shares. The filing reports the exchange but no resulting business gains or costs, so this alone does not change how we read Repligen.
Follow BioLife Solutions Inc (BLFS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BLFS